Search by Drug Name or NDC

NDC 00078-0650-06 FARYDAK 10 mg/1 Details

FARYDAK 10 mg/1

FARYDAK is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is PANOBINOSTAT LACTATE.

MedlinePlus Drug Summary

Panobinostat is used in combination with bortezomib (Velcade) and dexamethasone to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated two other medications, including bortezomib (Velcade). Panobinostat is in a class of medications called histone deacetylase (HDAC) inhibitors. It works by killing cancer cells.

Related Packages: 00078-0650-06
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Panobinostat

Product Information

NDC	00078-0650
Product ID	0078-0650_8d8f5dd5-879b-4f1a-a239-74ae9eb358fc
Associated GPIs	21531550100120
GCN Sequence Number	073586
GCN Sequence Number Description	panobinostat lactate CAPSULE 10 MG ORAL
HIC3	V3A
HIC3 Description	ANTINEOPLAST,HISTONE DEACETYLASE (HDAC) INHIBITORS
GCN	38008
HICL Sequence Number	041794
HICL Sequence Number Description	PANOBINOSTAT LACTATE
Brand/Generic	Brand
Proprietary Name	FARYDAK
Proprietary Name Suffix	n/a
Non-Proprietary Name	panobinostat
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	10
Active Ingredient Units	mg/1
Substance Name	PANOBINOSTAT LACTATE
Labeler Name	Novartis Pharmaceuticals Corporation
Pharmaceutical Class	Cytochrome P450 2D6 Inhibitors [MoA], Histone Deacetylase Inhibitor [EPC], Histone Deacetylase Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA205353
Listing Certified Through	n/a

Package

NDC 00078-0650-06 (00078065006)

Pricing Information	N/A
NDC Package Code	0078-0650-06
Billing NDC	00078065006
Package	6 CAPSULE in 1 BLISTER PACK (0078-0650-06)
Marketing Start Date	2015-02-23
NDC Exclude Flag	N